会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Hemostatic compositions and devices
    • 止血组合物和装置
    • US08119160B2
    • 2012-02-21
    • US11078049
    • 2005-03-11
    • Dwayne Lee LooneyGuanghui ZhangSonia Martins
    • Dwayne Lee LooneyGuanghui ZhangSonia Martins
    • A61K9/16B01D39/00B01D15/00
    • A61L24/104A61L24/0036A61L24/102
    • The present inventions includes a plurality of packed particles that contain interstitial pores, where the interstitial pores have a pore volume and a median pore diameter effective to provide improved absorption of physiological fluids or an aqueous media when placed in contact therewith, compared to a plurality of unpacked particles of the same material, where the particles are made of a biocompatible material and hemostatic agents and have an average diameter suitable for use in providing hemostasis to a site of a body of a mammal requiring hemostasis, hemostatic compositions containing such plurality of packed particles, methods of making such particles and compositions and medical devices suitable for delivering and containing the hemostatic plurality of particles and/or composition to a site of a body.
    • 本发明包括多个包含间质孔的填充颗粒,其中间隙孔具有孔容积和中值孔径,其有效地提供改善的生理流体吸收或与其接触时的水性介质,与多个 相同材料的未包装的颗粒,其中颗粒由生物相容性材料和止血剂制成,并且具有适合用于向要求止血的哺乳动物的身体的部位提供止血的平均直径,含有这种多个包装颗粒的止血组合物 制备这种颗粒和组合物的方法以及适于将止血多个颗粒和/或组合物输送并包含在身体部位的医疗装置。
    • 8. 发明授权
    • Nucleic acid encoding extracellular matrix protein or fragment thereof
    • 核酸编码细胞外基质蛋白或其片段
    • US06927287B1
    • 2005-08-09
    • US10153469
    • 2002-05-22
    • Elliott A. GruskinDouglas D. BuechterGuanghui ZhangKevin Connelly
    • Elliott A. GruskinDouglas D. BuechterGuanghui ZhangKevin Connelly
    • C07K14/51C07K14/78C12N1/21C12P21/02C07H21/02C07K14/435C12Q21/04
    • C12P21/02C07K14/51C07K14/78C07K2319/00
    • Incorporation of certain amino acid analogs into polypeptides produced by cells which do not ordinarily provide polypeptides containing such amino acid analogs is accomplished by subjecting the cells to growth media containing such amino acid analogs. The degree of incorporation can be regulated by adjusting the concentration of amino acid analogs in the media and/or by adjusting osmolality of the media. Such incorporation allows the chemical and physical characteristics of polypeptides to be altered and studied. In addition, nucleic acid and corresponding proteins including a domain from a physiologically active peptide and a domain from an extracellular matrix protein which is capable of providing a self-aggregate are provided. Human extracellular matrix proteins capable of providing a self-aggregate collagen are provided which are produced by prokaryotic cells. Preferred codon usage is employed to produce extracellular matrix proteins in prokaryotics.
    • 将某些氨基酸类似物掺入由通常不提供含有这种氨基酸类似物的多肽的细胞产生的多肽中,是通过使细胞经受含有这种氨基酸类似物的生长培养基来完成的。 可以通过调节培养基中氨基酸类似物的浓度和/或通过调节培养基的重量摩尔渗透压浓度来调节掺入程度。 这种结合允许改变和研究多肽的化学和物理特性。 此外,提供了核酸和相应的蛋白质,包括来自生理活性肽的结构域和能够提供自聚集体的细胞外基质蛋白的结构域。 提供能够提供自身骨胶原蛋白的人细胞外基质蛋白,其由原核细胞产生。 使用优选的密码子用于在原核生物中产生细胞外基质蛋白。